Investors were left disappointed as CareRx Corp reported a significant earnings miss, raising questions about future performance.
CareRx Corp's recent earnings report for the fiscal period ending June 30, 2026, revealed an unexpected downturn. The company posted earnings per share (EPS) of CAD 0.01, falling short of analyst estimates of CAD 0.03. This 66.67% miss is concerning for investors as the company navigates its financial path.
Recent earnings trend
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
CareRx Corp
CRRX.TO
CRRX.TO
CareRx Corp
WealthAwesomeMarket cap
$216.99M
P/E
8.0x
Div. yield
1.75%
Div. / share
$0.06
52W high
$3.95
52W low
$2.64
1W change
+6.29%
Beta
0.60
Analyst Price Targets
Based on analyst covering CRRX
Wall Street analysts forecast CRRX stock price to rise 44.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.14
+44.9% Upside
Current Price
C$3.55
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRRX's historical volatility
30-Day Vol
22.0%
Annualized
90-Day Vol
25.8%
Annualized
Trend (90d)
-12.8%
Annualized drift
90d Mean
C$3.39
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.50 | C$3.24 – C$3.77 |
| 60 trading days | C$3.44 | C$3.09 – C$3.83 |
| 90 trading days | C$3.39 | C$2.97 – C$3.87 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 1 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-06-30 | 2026-07-29 | 0.0100 | 0.0300 | -66.7% |
| 2026-03-31 | 2026-05-06 | 0.0200 | 0.0700 | -71.4% |
| 2025-12-31 | 2026-03-04 | 0.3700 | 0.0300 | +1133.3% |
| 2025-09-30 | 2025-11-03 | 0.0200 | 0.0300 | -33.3% |
| 2025-06-30 | 2025-07-30 | 0.0100 | 0.0100 | +0.0% |
| 2025-03-31 | 2025-05-07 | 0.0035 | 0.0100 | -65.0% |
Advertisement
Investor takeaway: Despite the earnings miss, CareRx's stock has shown resilience in the market. Recent gains suggest that some investors remain optimistic about the company's long-term prospects. However, the substantial deviation from expected earnings could indicate deeper issues that require close monitoring.
Earnings Miss by 66.67%
CareRx Corp's EPS of CAD 0.01 for Q2 2026 starkly contrasts with the expected CAD 0.03, highlighting ongoing challenges in meeting market expectations.
Bull case
CareRx has a solid foundation, with a low P/E ratio of 7.95 and a consistent dividend yield of 1.75%. If the company can leverage its existing strengths to improve operational efficiency and drive revenue growth, there is potential for recovery and increased investor confidence.
Bear case
The significant earnings miss and declining EPS trends raise concerns about CareRx's financial health. With only one earnings beat in the last four quarters and a potential slowdown in revenue growth, investors may need to reassess their positions if the company fails to reverse this trend.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
